Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.
Janeczko-Czarnecka M, Krawczuk-Rybak M, Karpińska-Derda I, Niedźwiecki M, Musioł K, Ćwiklińska M, Drabko K, Mycko K, Ociepa T, Pawelec K, Januszkiewicz-Lewandowska D, Ussowicz M, Rybka B, Ryczan-Krawczyk R, Kołtan A, Karolczyk G, Zaucha-Prażmo A, Badowska W, Kałwak K.
Janeczko-Czarnecka M, et al. Among authors: musiol k.
Adv Clin Exp Med. 2018 Jan;27(1):91-98. doi: 10.17219/acem/66462.
Adv Clin Exp Med. 2018.
PMID: 29521048
Free article.